Start Date
5-3-2024 9:10 AM
End Date
5-3-2024 11:00 AM
Description
Background
- Problem: Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) are liver diseases that have rapidly increased in the population over the last few years and are becoming an evercommon cause of liver failure and the need for liver transplant. Disease presence long predates concerning symptoms and many individuals will not be made aware until after the diseased has progressed in severity. Earlier intervention is often inhibited due to the need of invasive biopsy or specific lab testing not easily available leading to significant underdiagnosis of patients with early disease
- Project AIM: We sought to add a well-researched and independently verified equation known as the Liver Fibrosis Index-4 (FIB-4) to our EPIC EMR as a "dotphrase" in order to increase the capture rate of patients with early asymptomatic disease to improve outcomes and screening in the endocrinology department as the two highest risk patient populations, those with diabetes or obesity, are routinely seen in our clinics
Keywords
fatty liver, MAFLD, MASH, obesity, diabetes, screening
Included in
May 3rd, 9:10 AM
May 3rd, 11:00 AM
Early Non-Invasive Monitoring of Fatty Liver Disease Using EMR Software
Background
- Problem: Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) are liver diseases that have rapidly increased in the population over the last few years and are becoming an evercommon cause of liver failure and the need for liver transplant. Disease presence long predates concerning symptoms and many individuals will not be made aware until after the diseased has progressed in severity. Earlier intervention is often inhibited due to the need of invasive biopsy or specific lab testing not easily available leading to significant underdiagnosis of patients with early disease
- Project AIM: We sought to add a well-researched and independently verified equation known as the Liver Fibrosis Index-4 (FIB-4) to our EPIC EMR as a "dotphrase" in order to increase the capture rate of patients with early asymptomatic disease to improve outcomes and screening in the endocrinology department as the two highest risk patient populations, those with diabetes or obesity, are routinely seen in our clinics
Comments
Presented at the 2024 Jefferson Health Equity and Quality Improvement (HEQI) Summit.